Cited by 984Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology ResearchPain Mechanisms and Treatments

The DOI matches its Crossref record; 349 of the 351 references it cites were found in a registry or an index.

Cannabinoids and the expanded endocannabinoid system in neurological disorders

Cristino, Luigia, Bisogno, Tiziana, Di Marzo, Vincenzo·2020·Nature Reviews Neurology

Open this paper in CoChat — free account

Abstract

Anecdotal evidence that cannabis preparations have medical benefits together with the discovery of the psychotropic plant cannabinoid Δ 9-tetrahydrocannabinol (THC) initiated efforts to develop cannabinoid-based therapeutics. These efforts have been marked by disappointment, especially in relation to the unwanted central effects that result from activation of cannabinoid receptor 1 (CB1), which have limited the therapeutic use of drugs that activate or inactivate this receptor. The discovery of CB2 and of endogenous cannabinoid receptor ligands (endocannabinoids) raised new possibilities for safe targeting of this endocannabinoid system. However, clinical success has been limited, complicated by the discovery of an expanded endocannabinoid system - known as the endocannabinoidome - that includes several mediators that are biochemically related to the endocannabinoids, and their receptors and metabolic enzymes. The approvals of nabiximols, a mixture of THC and the non-psychotropic cannabinoid cannabidiol, for the treatment of spasticity and neuropathic pain in multiple sclerosis, and of purified botanical cannabidiol for the treatment of otherwise untreatable forms of paediatric epilepsy, have brought the therapeutic use of cannabinoids and endocannabinoids in neurological diseases into the limelight. In this Review, we provide an overview of the endocannabinoid system and the endocannabinoidome before discussing their involvement in and clinical relevance to a variety of neurological disorders, including Parkinson disease, Alzheimer disease, Huntington disease, multiple sclerosis, amyotrophic lateral sclerosis, traumatic brain injury, stroke, epilepsy and glioblastoma.

Integrity signals

Registry

Crossref · 10.1038/s41582-019-0284-z

Cites

349 of 349 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Anti-carcinogenic activity of anandamide on human glioma in vitro and in vivo
Ma, C., Wu, T., Jiang, P., Li, Z., Chen, X., FU, K., WANG, W., & Gong, R. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4721 · Cited by 27
Retracted
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., & Wright, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611618 · Cited by 1,711
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607

Show all 351 references

Sorted by citations

Items 901–984 of 984

Additional file 2 of Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice
Santos‐García, I., Rodríguez‐Cueto, C., Villegas, P., Piscitelli, F., Lauritano, A., Shen, C.-K. J., Marzo, V. D., Fernández‐Ruíz, J., & de Lago, E. (2024) · Figshare · doi:10.6084/m9.figshare.26587587
Additional file 4 of Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration
Galán-Ganga, M., Rodríguez‐Cueto, C., Merchán‐Rubira, J., Hernández, F., Ávila, J., Posada-Ayala, M., Lanciego, J. L., Luengo, E., Lopez, M. G., Rábano, A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14608966
Additional file 5 of Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration
Galán-Ganga, M., Rodríguez‐Cueto, C., Merchán‐Rubira, J., Hernández, F., Ávila, J., Posada-Ayala, M., Lanciego, J. L., Luengo, E., Lopez, M. G., Rábano, A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14608969
Additional file 1 of The attitudes, knowledge and confidence of healthcare professionals about cannabis-based products
Russo, E., Agredano, P. M., Flachenecker, P., Lawthom, C., Munro, D., Hindocha, C., Bagul, M., & Trinka, E. (2024) · Figshare · doi:10.6084/m9.figshare.26367996
Additional file 1 of Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice
Santos‐García, I., Rodríguez‐Cueto, C., Villegas, P., Piscitelli, F., Lauritano, A., Shen, C.-K. J., Marzo, V. D., Fernández‐Ruíz, J., & de Lago, E. (2024) · Figshare · doi:10.6084/m9.figshare.26587584
Additional file 3 of LTBP1 plays a potential bridge between depressive disorder and glioblastoma
Fu, X., Zhang, P., Song, H., Wu, C., Li, S., Li, S., & Yan, C. (2020) · Figshare · doi:10.6084/m9.figshare.13101186
Additional file 7 of Whole-genome resequencing of wild and cultivated cannabis reveals the genetic structure and adaptive selection of important traits
Chen, X., Guo, H.-Y., Zhang, Q., Wang, L., Guo, R., Zhan, Y.-X., Lv, P., Xu, Y.-P., 郭孟璧, Zhang, Y., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20381895
Additional file 1 of TNEA therapy promotes the autophagic degradation of NLRP3 inflammasome in a transgenic mouse model of Alzheimer’s disease via TFEB/TFE3 activation
Lin, W., Li, Z., Liang, G., Zhou, R., Zheng, X., Tao, R., Huo, Q., Su, C., Li, M., Xu, N., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612910
Additional file 1 of Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine
Greco, R., Demartini, C., Zanaboni, A. M., Francavilla, M., Reggiani, A. M., Realini, N., Scarpelli, R., Piomelli, D., & Tassorelli, C. (2022) · Figshare · doi:10.6084/m9.figshare.20267273
Additional file 5 of Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice
Santos‐García, I., Rodríguez‐Cueto, C., Villegas, P., Piscitelli, F., Lauritano, A., Shen, C.-K. J., Marzo, V. D., Fernández‐Ruíz, J., & de Lago, E. (2024) · Figshare · doi:10.6084/m9.figshare.26587596
Additional file 3 of Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice
Santos‐García, I., Rodríguez‐Cueto, C., Villegas, P., Piscitelli, F., Lauritano, A., Shen, C.-K. J., Marzo, V. D., Fernández‐Ruíz, J., & de Lago, E. (2024) · Figshare · doi:10.6084/m9.figshare.26587590
Additional file 9 of Whole-genome resequencing of wild and cultivated cannabis reveals the genetic structure and adaptive selection of important traits
Chen, X., Guo, H.-Y., Zhang, Q., Wang, L., Guo, R., Zhan, Y.-X., Lv, P., Xu, Y.-P., 郭孟璧, Zhang, Y., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20381901
Additional file 1 of LTBP1 plays a potential bridge between depressive disorder and glioblastoma
Fu, X., Zhang, P., Song, H., Wu, C., Li, S., Li, S., & Yan, C. (2020) · Figshare · doi:10.6084/m9.figshare.13101180
Tetrahydrocannabinol derivative ameliorates 5-FU mediated DNA damage propensity coupled with Vimentin suppression leading to autophagy inductionPreprint
Goswami, A., Mir, K. B., Chakraborty, S., Amin, T., Kumar, A., War, A. R., Nalli, Y., Kumar, R., Kumar, L. D., & Ali, A. (2023) · Research Square · doi:10.21203/rs.3.rs-3266520/v1
Additional file 1 of Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB1 receptor density in cell membranes: an alternative to radioligand binding methods
Saumell-Esnaola, M., Elejaga-Jimeno, A., Echeazarra, L., Roman, L. B., Barrondo, S., López de Jesús, M., González‐Burguera, I., Gómez‐Caballero, A., Goicolea, M. A., Sallés, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21130052
Additional file 8 of Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice
Santos‐García, I., Rodríguez‐Cueto, C., Villegas, P., Piscitelli, F., Lauritano, A., Shen, C.-K. J., Marzo, V. D., Fernández‐Ruíz, J., & de Lago, E. (2024) · Figshare · doi:10.6084/m9.figshare.26587605
Additional file 6 of Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice
Santos‐García, I., Rodríguez‐Cueto, C., Villegas, P., Piscitelli, F., Lauritano, A., Shen, C.-K. J., Marzo, V. D., Fernández‐Ruíz, J., & de Lago, E. (2024) · Figshare · doi:10.6084/m9.figshare.26587599
Additional file 9 of Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice
Santos‐García, I., Rodríguez‐Cueto, C., Villegas, P., Piscitelli, F., Lauritano, A., Shen, C.-K. J., Marzo, V. D., Fernández‐Ruíz, J., & de Lago, E. (2024) · Figshare · doi:10.6084/m9.figshare.26587608
Additional file 4 of Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice
Santos‐García, I., Rodríguez‐Cueto, C., Villegas, P., Piscitelli, F., Lauritano, A., Shen, C.-K. J., Marzo, V. D., Fernández‐Ruíz, J., & de Lago, E. (2024) · Figshare · doi:10.6084/m9.figshare.26587593
The Endocannabinoid System and Medicinal Cannabis
O’Brien, K., & Bosak, C. (2025) · Springer eBooks · doi:10.1007/978-3-032-01737-6_2
Acute pediatric cannabis toxicity
Massengill, D. L., Wang, G. S., & Halmo, L. S. (2026) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2026.100573
Illuminating chromaffin granules: compartmentalization of endocannabinoids in bovine adrenal glands supports role in hormone modulation
Roukens, J.-J., Meier, P., Simão, A. C., Chicca, A., Bregy, R., Altmann, K., & Gertsch, J. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117827
Synthetic cannabidiol analogues exhibit lower toxicity than cannabidiol and protect against ethanol-induced apoptosis in SH-SY5Y cells
Almeida, C. A. D. F., Salles, G., Bruno, V., Ribeiro, J. M., Silva, A. O., Braz, G. D. A., Castelhano, F. V. D., Franco, G. D. R. R., Viegas, C., Marcourakis, T., et al. (2026) · NeuroToxicology · doi:10.1016/j.neuro.2026.103411
Psychedelics and microglia in aging: unraveling the secret dialogue behind healthy aging, mental health, and neuroinflammation
Inserra, A., VanderZwaag, J., Campanale, A., Murray, C. J., & Szabo, A. J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27340-7.00008-5
Cannabinoids as modulators for Alzheimer’s disease: a role for microglia?
Vecchiarelli, H. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27340-7.00002-4
The Inhibitory Effects of a Peripherally Restricted CB1 Receptor Antagonist on Myofibroblast Transdifferentiation of Human Retinal Pigment Epithelial Cells
Zhao, D., Motheramgari, V., Shrader, S. H., Wang, W., Tamiya, S., & Song, Z.-H. (2026) · Cells · doi:10.3390/cells15050418
Tetracycline-Regulated Inducible CB 2 Expression in AtT20 Cells: A Functional Assay for Quantifying Ligand EfficacyPreprint
Foyzun, T., Connor, M. A., Zaman, H., Kassiou, M., Kallinen, A., & Santiago, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.26.708391
Effects and mechanisms of cannabidiol in attenuating orofacial inflammatory pain and ameliorating pain-related affective deficits
Wang, W., Xie, G., Xu, B., Xie, J., Cao, D., Song, X., Zou, W., Wu, N., Li, J., & Han, X. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.111813
Acute metabolic effects of cannabinoid receptor modulators during sequential hyperglycemic, euglycemic-hyperinsulinemic clamps in healthy individuals
Chia, C. W., Tang, E. Y., Cutler, R. G., You, S. S., Chen, Q., Choo, A. Y., Melvin, D. L., Ramsden, C. E., Kapogiannis, D., & Egan, J. M. (2026) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00391.2025
Cannabinoid exposure during pregnancy: Cardiorespiratory effects and offspring outcomes
Patrone, L. G. A., & Gargaglioni, L. H. (2026) · The Journal of Physiology · doi:10.1113/jp289280
Exploring cannabinoid receptor CB1 autophagy and the obesity phenotype of p62-deficient mice
Keller, C., Rading, S., Candur, B., Bîndilă, L., Loers, G., & Karsak, M. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102571
Role of the endocannabinoid system in exercise motivation
Redon, B. (2021) · theses.fr (ABES) · doi:10.70675/844c9d99zd3c6z4550z97a6zebab239b226c
Cannabinoid modulation of behavioral processes : from adolescence to adulthood
Ioannidou, C. (2021) · theses.fr (ABES) · doi:10.70675/85fe2023za70dz4d65z83c9z9828ec89522f
Linking medicinal cannabis to autotaxin lysophosphatidic acid signalling and development of cannabinoid-inspired inhibitors
Eymery, M. (2023) · doi:10.70675/d89a6883zb802z4d71z97b5z7e742a2dd3e5
Roles of the CB1 receptor and the endocannabinoid system in the retina
Beriain, S. (2024) · doi:10.70675/e533e89dz9455z4d6dz8599z1c85b7e5aa67
Cannabinoïdes et maladies neurodégénératives
Lacroix, C. (2023) · doi:10.70675/2b09dabez6ffcz4645z8843z242296b51bf8
Distribution and subacute modulation of endocannabinoid metabolizing enzymes in the trigeminal complex and midbrain in a pre-clinical model of post-traumatic headache
Nagarajan, G., & Zhang, Y. (2026) · The Journal of Headache and Pain · doi:10.1186/s10194-026-02356-5
Endocannabinoid Modulation of Different Memory Phases in the Hippocampus: Unveiling Causality in the CA1 Local Circuit
Quillfeldt, J. A., & Alvares, L. D. O. (2026) · Springer eBooks · doi:10.1007/978-3-032-12239-1_3
Therapeutically relevant rimonabant exposure drives epigenetic remodeling in neuronal cells and rat brain tissue
Marques, S. I., de Moura, M. B., Panza, F., Pereira-Teixeira, C., Stevanović, V., Kovačević, A., Savić, M. M., Carmo, H., Sá, S. I., Carvalho, F., et al. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04369-0
CANNABIS MEDICINAL EN CUIDADOS PALIATIVOS ONCOLÓGICOS: EVIDENCIA CLÍNICA PARA EL CONTROL DEL DOLOR Y LA NÁUSEA
Zuñiga, O. J., Alfaro, R. A., & Alcántara-Quintana, L. E. (2026) · Aracê. · doi:10.56238/arev8n4-068
Structural basis for positive allosteric regulation of CB2 receptor
Wang, X., Cai, Y., Yang, X., Wu, S., Xian, J., Wang, J., Lei, D., & Li, W. (2026) · Nature Communications · doi:10.1038/s41467-026-72923-6
Signaling lipids: An overview of emerging physiological functions
Saharan, O., Pal, T., & Kamat, S. S. (2026) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2026.102654
Cyclodextrin-based nanosponges for the solubility enhancement and delivery of a selective CB2 receptor ligand
Sandoval, S. S., Maine, A., Cortés‐Arriagada, D., Richter, S., Briones, X. G., Arellano, A., Jaque, P., Günther, G., & Romero, J. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108539
Betulinic acid regulates microglial polarization by inhibiting the phosphorylation of CB2 receptors thereby improving ischemic brain injury
Guo, Y., Wang, G., Tian, Q., Li, Y., Zhao, Q., Kang, Y., Liu, C., He, P., Wang, J., Liao, J., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158430
Mechanism of endocannabinoid system activation in regulating depression
Xin-Sheng, L. I. U., Liang, J., & Yan, L. I. (2026) · Shengming kexue · doi:10.3724/cbls.2026090
Probe-Based Chemical Proteomics Identifies UDP-Glucose 6-Dehydrogenase as a Potential Cannabidiol-Interacting Protein
Wang, X., Chu, F.-X., Zhou, S., Chen, B., Zou, S., Fei, Q., Ren, R., Su, M., & Di, B. (2026) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6c00586
Cannabidiol in biomedical research: Potential and challenges
Taha, L., Kammerer, S., Zschoche, N., Brauckhoff, T., Schierack, P., & Rödiger, S. (2026) · Journal of Cellular Biotechnology · doi:10.1177/23523689261464452
Endocannabinoid system modulation in bruxism: a neurobiological hypothesis and translational model of ECS-targeted intervention
da Rosa, R. A., & Caldas, R. A. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1854001
Cannabinoids in peripheral neuropathic pain: Resolving mechanistic mismatch through CB2-oriented phenotype stratification
Bagher, A. M. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179130
Real-world quality of life and sleep outcomes in patients treated with THC- and CBD-rich Cannabis oil: a cross-sectional study
Figueiredo, J. F. L. M., Soares, C. D. A., de Oliveira, D. A., Cassiano, F. R., Sacramento, V. D. M., Júnior, A. F. D. M., Menezes, E. V., Brandão, M. M., & Royo, V. D. A. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1862725
Cross-species causal gene mapping reveals brain-region-specific targets of Cannabidiol for post-traumatic stress disorder treatment
Rao, H., Xie, G., Wu, N., Li, J., & Han, X. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154347
Brain cannabinoid CB1 receptor signaling modulates reward responses and inhibitory control in humans
Sun, L., Kantonen, T., Pekkarinen, L., Nuutila, P., & Nummenmaa, L. (2026) · Imaging Neuroscience · doi:10.1162/imag.a.1344
Preclinical evidence of neuroprotective effects of endocannabinoids and related lipid molecules in ischemic stroke: a systematic review and meta-analysis of animal studies
Li, X., Wen, L., Du, Y., Zhou, J., Xue, N., Fan, X., Zhao, H., & Qu, M. (2026) · European journal of medical research · doi:10.1186/s40001-026-04990-w
Cannabinoid therapeutics in the 21st century: from molecular mechanisms to equitable clinical integration
Oso, T. A., Adebayo, U. O., Ngwoke, I., Okesanya, O. J., Ogunmuyiwa-James, M. E., Ahmed, M. M., Obadeyi, K. B., Ayelaagbe, O. B., Eshun, G., & Lucero‐Prisno, D. E. (2026) · Exploration of Drug Science · doi:10.37349/eds.2026.1008177
Medical cannabis in older adults: real-world evidence from a retrospective observational studyPreprint
Moreno-Monroy, C. S., Díaz-Moreno, I. D., Maiorana, S., López‐Ejeda, N., Pineda, P., & Sánchez, C. (2026) · Research Square · doi:10.21203/rs.3.rs-10703452/v1
Reduction of Microglial Reactivity by Cannabidiol: Preliminary Data Obtained in an Astrocyte–Microglia Co-Culture Model of Inflammation
Schönfelder, L., An, S., Reusch, P., Faustmann, P. M., Faustmann, T. J., & Ismail, F. S. (2026) · Pharmaceuticals · doi:10.3390/ph19091342
Cannabinoid receptor agonist WIN 55,212-2 modulates systemic inflammatory and oxidative stress responses in streptozotocin-induced diabetic rats
Tombultürk, F. K., Dedeakayoğulları, H., Seven, Z. G. T., & Uyanık, K. Ç. P. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02372-6
Synthetic Cannabinoids: A Bibliometric Analysis
Kamalak, M., Gulderen, A., & Parlak, M. E. (2026) · Turkish Journal of Forensic Medicine · doi:10.61970/adlitip.1943550
Integrated Metabolomic and Proteomic Analyses Reveal Differential Regulation of the Citrate Cycle and Pentose Phosphate Pathway by Cannabis sativa Extract and the Synthetic Cannabinoid HU210 in GT1-7 Neuronal Cells: Sequential Extraction of Metabolites and Proteins from a Single Cell Pellet
Natori, Y., Mizuno, D., Doshi, M., Kawahara, M., & Ishii, A. (2026) · Metabolites · doi:10.3390/metabo16090645
Cannabinoids and therapeutic potential in neuropsychiatry
Ertenu, D. D., Papolu, A., Anderson, N., Wecker, E., Hauptman, A. J., & Salpekar, J. A. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.08.030
Modulation of the Endocannabinoid System by Cannabis sativa Bioactives in Alzheimer’s Disease: Therapeutic and Nutritional Implications
Rachelle, É. F., Vanz, J. B., Hennig, B. D. L., Roman, S. S., Steffens, J., & Steffens, C. (2026) · Applied Sciences · doi:10.3390/app16189171
Lipidomic Evidence for Cannabidiol-Induced Remodeling of Cellular Lipid Composition in SH-SY5Y Cells
Walzer, O., Erhardt, V. K. J., Zügner, J. S. R., Izarova, N. V., Endres, K., Grimm, H. S., Hartmann, T., & Grimm, M. O. W. (2026) · Cells · doi:10.3390/cells15181714
The impact of oil encapsulation on its digestion and the consequences for the metabolic fate of fatty acids: the case of DHA oil
Pédrono, F., & Dupont, D. (2026) · OCL · doi:10.1051/ocl/2026028
Phytocannabinoid-drug interactions: pharmacokinetic and pharmacodynamic mechanisms, clinical relevance and toxicological considerations
Gomes, D. A., Eufrazio, W. V., Ribeiro, M. S., Júnior, L. R. D. N., Rigo, F. K., Amaral, P. D. A., Campanale, A., Inserra, A., & de Bitencourt, R. M. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2026.1952599 · Cited by 1
Editorial: Novel pharmacological interventions in emotional and neuropsychiatric disorders
García-Baos, A., Stamenić, T. T., Fiedler, J. L., & Kusljic, S. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1974847
Fungal Metabolites as Multi-Target Modulators of Alzheimer’s Disease: An Integrated In Silico Docking and Molecular Dynamics Approach
Vijayan, D., Siva, K., Ramachandran, J., & Saravanan, D. (2026) · Malaysian Applied Biology · doi:10.55230/mabjournal.v55i3.3751
Cannabinoids in oncology: pharmacology, clinical applications, and translational perspectives
Safran, E., Safran, H. P., & Kim, S. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1969657
Acidic cannabinoids in brain disorders: Neurobiological mechanisms, preclinical evidence, and translational challenges
Rava, A., Trapano, M. D., Tse, C., Ji, L., Bid, H. K., & Trezza, V. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.107005
Involvement of CB1 and CB2 receptors in neuroprotective effects of cannabinoids
de Lago, E., Ruiz, J. F., & Rodríguez‐Cueto, C. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34176-2.00011-0
Microglial Therapeutic Potential in Alzheimer’s Disease: From Phenotypic Diversity to Targeted Interventions
Gogu, M.-R., Costăchescu, I., Stanciu, G. D., Tamba, B.-I., Ciorpac, M., & Gorgan, L. (2026) · Pharmaceuticals · doi:10.3390/ph19101603
Chemical Stabilization and Retention-Predictive Modeling for Regiospecific Profiling of Labile Monoacylglycerols by UHPLC–HRMS
Zhou, J., Zhang, Y., Wen, L.-L., Du, Y., Zheng, W.-C., Duan, X.-X., Qu, M., Zhao, H., & Wan, J. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.6c05265
Synthetic Cannabinoids: Metabolism, Biomarkers of Exposure and Advanced Analytical Strategies in Forensic and Clinical Toxicology
Gomes, T. M., de Pinho, P. G., Nunes, I., & Câmara, J. S. (2026) · Toxics · doi:10.3390/toxics14100898
Diphenylpyraline Derivatives Are Allosteric Agonists of the CB1 Cannabinoid Receptor
Eldeeb, K., Harp, J. J., Fitzgerald, R. W., Leone‐Kabler, S., Reeves, T. E., Jones, S. R., Childers, S. R., Howlett, A. C., & Pulgar, V. M. (2026) · Molecules · doi:10.3390/molecules31203699
Athletes and Medical Staff in Elite Contact Sports: a Quantitative Analysis of Use, Knowledge, and Attitudes Regarding Cannabinoids
Thompson, E. S., Alcorn, J., Laprairie, R., Rohatinsky, N., Dehghani, P., & Neary, J. P. (2026) · Sports Health A Multidisciplinary Approach · doi:10.1177/19417381261495512
Cannabinoids in Psoriasis: From Cutaneous Endocannabinoid Biology to Emerging Clinical Evidence
Krefta, E., Pires, D. T., Cezar‐dos‐Santos, F., & do Nascimento, F. P. (2026) · Biomedicines · doi:10.3390/biomedicines14112432
BindingDB Entry 50021172: Novel pyrrole based CB2 agonists: New insights on CB2 receptor role in regulating neurotransmitters' tone.
BindingDB (2025) · UC San Diego · doi:10.7270/q2xg9wqd
BindingDB Entry 50014315: Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease.
BindingDB (2022) · UC San Diego · doi:10.7270/q2h41w7x
BindingDB Entry 50017602: Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists.
BindingDB (2023) · UC San Diego · doi:10.7270/q2j96bfx
BindingDB Entry 50015064: Novel Functionalized Cannabinoid Receptor Probes: Development of Exceptionally Potent Agonists.
BindingDB (2023) · UC San Diego · doi:10.7270/q2tb1bsb
BindingDB Entry 50022770: Stereoisomers of cannabidiols and their pharmacological activities - A potentially novel direction for cannabinoids.
BindingDB (2026) · UC San Diego · doi:10.7270/q27p947w
BindingDB Entry 50015651: Carbon-silicon switch led to the discovery of novel synthetic cannabinoids with therapeutic effects in a mouse model of multiple sclerosis.
BindingDB (2023) · UC San Diego · doi:10.7270/q2pk0m3g
BindingDB Entry 50016273: Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease.
BindingDB (2023) · UC San Diego · doi:10.7270/q2js9vf3
BindingDB Entry 50019172: Development of
BindingDB (2024) · UC San Diego · doi:10.7270/q2x92gn5
Altered Sphingolipid–N-Acylethanolamine Signaling Reveals Peripheral Lipid Remodeling in First-Episode SchizophreniaPreprint
Zheng, F., Liu, M., Qin, X., Zhao, H., Zhu, Y., He, Y., Zhou, F., & Zuoli, S. (2026) · Research Square · doi:10.21203/rs.3.rs-11290648/v1

Authors: Cristino, L., Bisogno, T., & Di Marzo, V.
Affiliations: Istituto di Chimica Biomolecolare (IT)
Istituto di Farmacologia Traslazionale (IT)
ORCID: Cristino, Luigia
Bisogno, Tiziana
Di Marzo, Vincenzo
Venue: Nature Reviews Neurology
Publisher: Springer Science and Business Media LLC
Published: 2019-12-12
Volume: 16
Issue: 1
Pages: 9-29
ISSN: 1759-4758 (ISSN-L)
1759-4766
DOI: 10.1038/s41582-019-0284-z
OpenAlex: W2996080671
Cited by: 970
References: 351
Citations by year: 2026: 79 · 2025: 126 · 2024: 173 · 2023: 185 · 2022: 183 · 2021: 142 · 2020: 82
FWCI: 13.33
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Reviews Neurology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
Keywords: cannabinoids, endocannabinoid system, endocannabinoidome, neurological disorders, CB1 receptor, CB2 receptor, nabiximols, cannabidiol, THC, multiple sclerosis, spasticity, neuropathic pain, pediatric epilepsy, Parkinson's disease, Alzheimer's disease, Huntington's disease, amyotrophic lateral sclerosis, traumatic brain injury, stroke, glioblastoma
MeSH terms: Analgesics, Animals, Cannabidiol, Cannabinoids, Drug Combinations, Humans, Nervous System Diseases, Dronabinol, Receptor, Cannabinoid, CB1, Receptor, Cannabinoid, CB2, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cannabinoids and the expanded endocannabinoid system in neurological disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks